CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 54 enrolled
Drug / intervention
Unicirc circumcisiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02593630
NCT02593630Phase 4Completed
CompareCT.gov

Field Study of Unicirc Circumcision in Adolescent Boys, Aged 12 to 15 Years.

Simunye Primary Health Care·interventional·Posted Nov 2, 2015·Updated Feb 4, 2019

In Brief

A Phase 4 clinical trial evaluating Unicirc circumcision for Circumcision, Male. Completed, enrolled 54 participants across 1 site.

Detailed Summary

This is a field case series of Unicirc under topical anaesthetic among adolescent boys, aged 12 to 15 years.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCircumcision, Male
CountriesSouth Africa
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedNov 2, 2015
Enrollment StartApr 1, 2016
Primary CompletionNov 15, 2016
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 10.7 years ago

Interventions

Unicirc circumcisiondevice

Unicirc circumcision under topical (EMLA) anaesthesia, wound sealing with cyanoacrylate tissue adhesive